Michael Halstead sold $3.7M of Intra-Cellular Therapies (ITCI)

Executed Nov 12 2024, disclosed Nov 14 2024, 2 days later.

Value, as filed

$3.7M

41,583 sh across 5 lots

Executed

Nov 12 2024

the trade date, as filed

Disclosed

Nov 14 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MH Michael Halstead President profile →

Michael Halstead (President) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in CYBN. The largest single filing was $1.3M of CYBN (100,000 sh × $13.47, as filed), executed Sep 21. The median gap between execution and disclosure was 0 days.

The name

ITCI ITCI ITCI · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→